Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -512.70% is 74% below its 5-year average of -294.03%, around the middle of its 5-year range (-853.57%–-121.50%).
12.39% above its 12-month average of -585.23%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -595.61%.
EBITDA MARGIN
-512.70%
EBITDA MARGIN AVG TTM
-585.23%
EBITDA MARGIN AVG 3Y
-380.44%
EBITDA MARGIN AVG 5Y
-294.03%
EBITDA MARGIN AVG 10Y
-1236.02%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+12.39%
CURRENT VS 3Y AVG
-34.77%
CURRENT VS 5Y AVG
-74.37%
CURRENT VS 10Y AVG
+58.52%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Ocular Therapeutix, Inc.
Market Cap
$1.63B
EBITDA Margin
-512.70%
TTM Avg
-585.23%
3Y Avg
-380.44%
5Y Avg
-294.03%
Market Cap
$1.63B
EBITDA Margin
0.06%
TTM Avg
-4.29%
3Y Avg
-15.38%
5Y Avg
-22.40%
Market Cap
$1.62B
EBITDA Margin
-172.34%
TTM Avg
-3780.22%
3Y Avg
-1874.89%
5Y Avg
-1874.89%
Market Cap
$1.62B
EBITDA Margin
19.54%
TTM Avg
15.33%
3Y Avg
15.07%
5Y Avg
12.91%
Market Cap
$1.61B
EBITDA Margin
-164.52%
TTM Avg
-214.39%
3Y Avg
-473.06%
5Y Avg
-473.06%
Market Cap
$1.60B
EBITDA Margin
-1075.09%
TTM Avg
-854.02%
3Y Avg
-886.21%
5Y Avg
-631.69%
Market Cap
$1.69B
EBITDA Margin
-2113.29%
TTM Avg
-2694.15%
3Y Avg
-1820.79%
5Y Avg
-1820.79%
Market Cap
$1.57B
EBITDA Margin
-10.20%
TTM Avg
-140.78%
3Y Avg
-597.36%
5Y Avg
-597.36%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ocular Therapeutix, Inc. (OCUL) | $1.63B | -512.70% | -585.23% | -380.44% | -294.03% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.63B | 0.06% | -4.29% | -15.38% | -22.40% |
| Septerna Inc (SEPN)vs › | $1.62B | -172.34% | -3780.22% | -1874.89% | -1874.89% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 19.54% | 15.33% | 15.07% | 12.91% |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 8.30% | 8.20% | 7.63% | 9.66% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.61B | -164.52% | -214.39% | -473.06% | -473.06% |
| uniQure N.V. (QURE)vs › | $1.60B | -1075.09% | -854.02% | -886.21% | -631.69% |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.69B | -2113.29% | -2694.15% | -1820.79% | -1820.79% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | -10.20% | -140.78% | -597.36% | -597.36% |
| Personalis, Inc. (PSNL)vs › | $1.71B | -112.01% | -89.88% | -115.02% | -95.96% |
Gross Margin
87.1%
EBITDA Margin
-512.7%
Operating Margin
-521.0%
Net Margin
-579.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -595.61% |
| 2026-03-31 | -853.57% |
| 2025-12-31 | -517.08% |
| 2025-09-30 | -464.98% |
| 2025-06-30 | -494.95% |
| 2025-03-31 | -588.30% |
| 2024-12-31 | -290.51% |
| 2024-09-30 | -291.99% |
| 2024-06-30 | -259.32% |
| 2024-03-31 | -207.78% |
| 2023-12-31 | -128.99% |
| 2023-09-30 | -121.50% |
| 2023-06-30 | -131.16% |
| 2023-03-31 | -164.99% |
| 2022-12-31 | -134.07% |
| 2022-09-30 | -175.80% |
| 2022-06-30 | -157.87% |
| 2022-03-31 | -131.01% |
| 2021-12-31 | -142.01% |
| 2021-09-30 | -155.81% |
| 2021-06-30 | -167.43% |
| 2021-03-31 | -266.71% |
| 2020-12-31 | -186.09% |
| 2020-09-30 | -227.04% |
| 2020-06-30 | -1094.77% |
| 2020-03-31 | -608.66% |
| 2019-12-31 | -918.75% |
| 2019-09-30 | -2711.10% |
| 2019-06-30 | -3259.69% |
| 2019-03-31 | -3837.80% |
| 2018-12-31 | -3313.69% |
| 2018-09-30 | -2860.04% |
| 2018-06-30 | -2005.86% |
| 2018-03-31 | -3791.18% |
| 2017-12-31 | -2502.67% |
| 2017-09-30 | -2813.38% |
| 2017-06-30 | -4106.16% |
| 2017-03-31 | -3244.42% |
| 2016-12-31 | -2391.19% |
| 2016-09-30 | -1891.40% |
| 2016-06-30 | -2471.66% |
| 2016-03-31 | -2249.78% |
| 2015-12-31 | -2310.78% |
| 2015-09-30 | -2559.44% |
| 2015-06-30 | -2058.39% |
| 2015-03-31 | -1629.11% |
| 2014-12-31 | -1461.98% |
| 2014-09-30 | -4641.26% |
| 2014-06-30 | -5974.23% |
| 2014-03-31 | -24933.33% |
